| Financial Year |
March 31 2022 |
| Monetary Funds |
229,353,383.17 |
| Held-for-trading Financial Assets |
422,040,584.37 |
| Notes Receivable |
-- |
| Accounts Receivable |
41,155,923.69 |
| Advances to Suppliers |
11,673,906.24 |
| Other Receivables |
5,458,993.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
547,184.35 |
| Inventories |
25,171,064.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,188,454.25 |
| Total Current Assets |
744,042,309.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
76,311,541.48 |
| Investment Properties |
546,502,300.36 |
| Fixed Assetes |
115,284,204.61 |
| Under-construction Projects |
247,782,527.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
49,276,334.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
27,678,464.72 |
| Deferred Income Tax Assets |
8,499,551.03 |
| Other Non-Current Assets |
59,760,715.49 |
| Sub-Total of Non-Current Assets |
1,148,197,400.38 |
| Total Assets |
1,892,239,709.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,802,428.81 |
| Accounts Received In Advance |
3,395,626.56 |
| Employee Compensation Payable |
37,852,463.24 |
| Taxes Payable |
28,530,459.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
119,629,681.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,023,464.61 |
| Other Current Liabilities |
809,386.56 |
| Sub-Total of Current Liabilities |
272,444,199.65 |
| Long-term Loans |
109,996,738.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,920,160.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
268,414.80 |
| Deferred Income Tax Liabilities |
963,045.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
129,195,062.19 |
| Total Liabilities |
401,639,261.84 |
| Paid-In Capital(Or Share Stock) |
431,058,320.00 |
| Capital Surplus |
431,449,554.51 |
| Surplus Reserve |
26,546,480.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
577,650,856.38 |
| Minority Stockholder's Interest |
23,868,814.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,466,731,632.98 |
| Owner's Equity（Stockholder's Equity） |
1,490,600,447.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,892,239,709.71 |
